514 related articles for article (PubMed ID: 11689684)
21. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
[TBL] [Abstract][Full Text] [Related]
22. Analysis of methylation pattern in multiple myeloma.
San-Miguel J; García-Sanz R; López-Pérez R
Acta Haematol; 2005; 114 Suppl 1():23-6. PubMed ID: 16166769
[TBL] [Abstract][Full Text] [Related]
23. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
[TBL] [Abstract][Full Text] [Related]
24. Methyl CpG-binding proteins and transcriptional repression.
Wade PA
Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
[TBL] [Abstract][Full Text] [Related]
25. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms.
Taniguchi Y; Nosaka K; Yasunaga J; Maeda M; Mueller N; Okayama A; Matsuoka M
Retrovirology; 2005 Oct; 2():64. PubMed ID: 16242045
[TBL] [Abstract][Full Text] [Related]
26. Treatment of tumor cells with histone deacetylase inhibitors results in altered recruitment of methyl-CpG binding proteins to a methylated CpG island.
Koizume S; Tachibana K; Shiraishi M
Biol Chem; 2003 May; 384(5):787-90. PubMed ID: 12817475
[TBL] [Abstract][Full Text] [Related]
27. Active repression of methylated genes by the chromosomal protein MBD1.
Ng HH; Jeppesen P; Bird A
Mol Cell Biol; 2000 Feb; 20(4):1394-406. PubMed ID: 10648624
[TBL] [Abstract][Full Text] [Related]
28. Methyl-CpG-binding proteins. Targeting specific gene repression.
Ballestar E; Wolffe AP
Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
Danam RP; Howell SR; Brent TP; Harris LC
Mol Cancer Ther; 2005 Jan; 4(1):61-9. PubMed ID: 15657354
[TBL] [Abstract][Full Text] [Related]
30. Proviral silencing in embryonic cells is regulated by Yin Yang 1.
Schlesinger S; Lee AH; Wang GZ; Green L; Goff SP
Cell Rep; 2013 Jul; 4(1):50-8. PubMed ID: 23810560
[TBL] [Abstract][Full Text] [Related]
31. Profiling methyl-CpG specific determinants on transcriptionally silent chromatin.
El-Osta A; Baker EK; Wolffe AP
Mol Biol Rep; 2001; 28(4):209-15. PubMed ID: 12153140
[TBL] [Abstract][Full Text] [Related]
32. Gene silencing. Methylation meets acetylation.
Bestor TH
Nature; 1998 May; 393(6683):311-2. PubMed ID: 9620794
[No Abstract] [Full Text] [Related]
33. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
Nan X; Campoy FJ; Bird A
Cell; 1997 Feb; 88(4):471-81. PubMed ID: 9038338
[TBL] [Abstract][Full Text] [Related]
34. Gene silencing by methyl-CpG-binding proteins.
Nan X; Cross S; Bird A
Novartis Found Symp; 1998; 214():6-16; discussion 16-21, 46-50. PubMed ID: 9601009
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic mechanism of rRNA gene silencing: temporal order of NoRC-mediated histone modification, chromatin remodeling, and DNA methylation.
Santoro R; Grummt I
Mol Cell Biol; 2005 Apr; 25(7):2539-46. PubMed ID: 15767661
[TBL] [Abstract][Full Text] [Related]
36. De novo methylation of MMLV provirus in embryonic stem cells: CpG versus non-CpG methylation.
Dodge JE; Ramsahoye BH; Wo ZG; Okano M; Li E
Gene; 2002 May; 289(1-2):41-8. PubMed ID: 12036582
[TBL] [Abstract][Full Text] [Related]
37. Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET.
Matsui T; Leung D; Miyashita H; Maksakova IA; Miyachi H; Kimura H; Tachibana M; Lorincz MC; Shinkai Y
Nature; 2010 Apr; 464(7290):927-31. PubMed ID: 20164836
[TBL] [Abstract][Full Text] [Related]
38. Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer.
Nakagawachi T; Soejima H; Urano T; Zhao W; Higashimoto K; Satoh Y; Matsukura S; Kudo S; Kitajima Y; Harada H; Furukawa K; Matsuzaki H; Emi M; Nakabeppu Y; Miyazaki K; Sekiguchi M; Mukai T
Oncogene; 2003 Dec; 22(55):8835-44. PubMed ID: 14647440
[TBL] [Abstract][Full Text] [Related]
39. Methyl-CpG-binding domain proteins: readers of the epigenome.
Du Q; Luu PL; Stirzaker C; Clark SJ
Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
[TBL] [Abstract][Full Text] [Related]
40. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
